Literature DB >> 20971773

Benign papilloma without atypia diagnosed at US-guided 14-gauge core-needle biopsy: clinical and US features predictive of upgrade to malignancy.

Ji Hyun Youk1, Eun-Kyung Kim, Jin Young Kwak, Eun Ju Son, Byeong-Woo Park, Seung-Il Kim.   

Abstract

PURPOSE: To evaluate the diagnostic accuracy of ultrasonographically (US)-guided 14-gauge core-needle biopsy (CNB) for benign papilloma without atypia and to determine whether clinical and radiologic features could be used to predict an upgrade to malignancy.
MATERIALS AND METHODS: This was an institutional review board-approved retrospective study, with a waiver of informed consent. The histologic results of US-guided CNB procedures performed from January 2006 through January 2009 were reviewed. A total of 160 benign papillomas without atypia that were diagnosed at CNB and excised surgically in 143 women (age range, 19-77 years) were assessed. Medical records and sonograms in the women were reviewed. Two radiologists working in consensus correlated imaging findings with the biopsy result to determine concordance. For the upgrade to malignancy after excision, malignant lesions were compared with nonmalignant lesions for the collected clinical and radiologic variables, which included patient age, lesion size, and lesion distance from the nipple, by using the χ(2) or Fisher exact test for categoric variables and the Mann-Whitney U test for continuous variables.
RESULTS: Eight (5.0%) of 160 papillomas were upgraded to malignancy. Lesions that were 1 cm or larger (seven [11%] of 63) showed a higher upgrade rate than lesions that were smaller than 1 cm (one [1%] of 97) (P = .006). The upgrade rate was higher in patients aged 50 years or older (six [16%] of 37) than in patients younger than 50 years (two [2%] of 123) (P = .002). Lesions that were 3 cm or farther from the nipple (four [13%] of 31) showed a higher upgrade rate than lesions that were less than 3 cm from the nipple (four [3.1%] of 129) (P = .046). Upgrade rates for Breast Imaging Reporting and Data System (BI-RADS) category 3, 4a, 4b, 4c, and 5 lesions were 0%, 2.5%, 6%, 27%, and 25%, respectively (P = .010).
CONCLUSION: At US-guided 14-gauge CNB, benign papilloma without atypia could be diagnosed accurately. Discordance between imaging and pathology results, as well as patient age of 50 years or older, lesion size of 1 cm or greater, lesion distance from the nipple of 3 cm or greater, and BI-RADS category may be helpful in predicting the possibility of upgrade to malignancy. © RSNA, 2010.

Entities:  

Mesh:

Year:  2010        PMID: 20971773     DOI: 10.1148/radiol.10100728

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  21 in total

1.  Benign papillomas without atypia diagnosed on core needle biopsy: experience from a single institution and proposed criteria for excision.

Authors:  Anupma Nayak; Selin Carkaci; Michael Z Gilcrease; Ping Liu; Lavinia P Middleton; Roland L Bassett; Jinxia Zhang; Hong Zhang; Robin L Coyne; Therese B Bevers; Nour Sneige; Lei Huo
Journal:  Clin Breast Cancer       Date:  2013-10-08       Impact factor: 3.225

Review 2.  Non-malignant breast papillary lesions - b3 diagnosed on ultrasound--guided 14-gauge needle core biopsy: analysis of 114 cases from a single institution and review of the literature.

Authors:  Simonetta Bianchi; Benedetta Bendinelli; Valeria Saladino; Vania Vezzosi; Beniamino Brancato; Jacopo Nori; Domenico Palli
Journal:  Pathol Oncol Res       Date:  2015-01-10       Impact factor: 3.201

3.  Outcomes of benign intraductal papillomas diagnosed on core biopsy: a review of 104 cases with subsequent excision from a single institution.

Authors:  Jaya Ruth Asirvatham; Julie M Jorns; Lili Zhao; Deborah O Jeffries; Angela J Wu
Journal:  Virchows Arch       Date:  2018-09-06       Impact factor: 4.064

4.  Outcomes of classic lobular neoplasia diagnosed on breast core needle biopsy: a retrospective multi-center study.

Authors:  Iskender Sinan Genco; Bugra Tugertimur; Qing Chang; Lauren Cassell; Sabina Hajiyeva
Journal:  Virchows Arch       Date:  2019-11-27       Impact factor: 4.064

5.  Papillary breast lesions on contrast-enhanced ultrasound: morphological enhancement patterns and diagnostic strategy.

Authors:  Han-Sheng Xia; Xi Wang; Hong Ding; Jie-Xian Wen; Pei-Li Fan; Wen-Ping Wang
Journal:  Eur Radiol       Date:  2014-08-23       Impact factor: 5.315

6.  Role of sonographic elastography in the differential diagnosis of papillary lesions in breast.

Authors:  Jae Jeong Choi; Bong Joo Kang; Sung Hun Kim; Ji Hye Lee; Seung Hee Jeong; Hyeon Woo Yim; Byung Joo Song; Sang Seol Jung
Journal:  Jpn J Radiol       Date:  2012-03-22       Impact factor: 2.374

7.  Treatment and Outcome of 341 Papillary Breast Lesions.

Authors:  Peixian Chen; Dan Zhou; Chuan Wang; Guolin Ye; Ruilin Pan; Lewei Zhu
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

8.  Do clinical and radiologic features help predict malignancy of B3 breast lesions without epithelial atypia (B3a)?

Authors:  Iliana Bednarova; Viviana Londero; Anna Linda; Rossano Girometti; Michele Lorenzon; Sandra Bednarova; Chiara Zuiani
Journal:  Radiol Med       Date:  2018-07-05       Impact factor: 3.469

9.  Are we overtreating intraductal papillomas?

Authors:  Sayee Kiran; Young Ju Jeong; Maria E Nelson; Alexander Ring; Meade B Johnson; Pulin A Sheth; Yanling Ma; Stephen F Sener; Julie E Lang
Journal:  J Surg Res       Date:  2018-06-29       Impact factor: 2.192

10.  Clinics in diagnostic imaging (180). Ductal carcinoma in situ (DCIS).

Authors:  Eu Jin Tan; Tammy Hui Lin Moey; Preetha Madhukumar; Lester Chee Hao Leong
Journal:  Singapore Med J       Date:  2017-10       Impact factor: 1.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.